Up-regulation of both KMO and KYNU in glioma may lead to increased production of 3-HK and 3-HAA, which may contribute to creating an immunosuppressive micromilieu by accumulating tryptophan toxic metabolites. Here, KMO is linked to central nervous system cancer.